Importance of MACC1 expression in breast cancer and its relationship with pathological prognostic markers

被引:7
|
作者
Soyleyici, Nevroz A. [1 ]
Aslan, Figen [2 ]
Avcikurt, Ayla S. [3 ]
Akgun, Gizem A. [4 ]
机构
[1] BaliKesir Univ, Inst Hlth Sci, Dept Pathol, Cagis Yerleskesi,Bigadic Yolu 17 Km Altieylul, BaliKesir, Turkey
[2] BaliKesir Univ, Dept Pathol, Sch Med, Cagis Yerleskesi,Bigadic Yolu 17 Km Altieylul, TR-10145 BaliKesir, Turkey
[3] BaliKesir Univ, Sch Med, Dept Med Biol, Cagis Yerleskesi,Bigadic Yolu 17 Km Altieylul, BaliKesir, Turkey
[4] Dumlupinar Univ, Sch Med, Dept Pathol, Merkez Kutahya, Turkey
关键词
Breast cancer; expression; Metastasis Associated Colon Cancer Gene 1; prognostic marker; COLON CANCER-1; POOR-PROGNOSIS; GROWTH-FACTOR; CARCINOMA; MET; ANGIOGENESIS; LEVEL;
D O I
10.4103/IJPM.IJPM_658_19
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Metastasis associated colon cancer gene 1 (MACC1) is a gene that was first described as a c-Met transcription regulator causing the progression of colon cancer. In this study, protein and messenger RNA (mRNA) expression of MACC1 in breast cancer and its relationship with clinicopathological prognostic parameters were investigated. Methods: Sixty-six cases with tumors underwent radical mastectomy for invasive ductal carcinoma and 25 control cases operated for mammoplasty were included in the study. In paraffin blocks of tumor and control tissues, MACC1 expression was investigated by the immunohistochemical method and Real-time polymerase chain reaction (Real-Time PCR). In addition, vascular endothelial growth factor (VEGF) expression was examined immunohistochemically in tumor tissues. The relationship between MACC1 expression in tumor tissues, clinicopathological prognostic parameters, and VEGF was investigated. Results: In this study, protein and mRNA expressions of MACC1 were found to be higher in tumor tissues compared with normal breast tissues. MACC1 protein expression was also associated with significant poor prognostic markers, such as high histologic grade, ER negativity, and HER2 positivity. However, there was no correlation between MACC1 expression and VEGF. Conclusion: According to these results, MACC1 expression may be a marker of breast carcinoma as well as an independent predictor of poor prognosis. In addition, MACC1 may not affect angiogenesis in breast cancer or even if it has an effect, it may not be associated with VEGF. However, it would be appropriate to support these results in a larger series by investigating in vivo and in vitro studies.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 50 条
  • [31] Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer
    Zhiqiang Wang
    Ming Cai
    Yuan Weng
    Fang Zhang
    Dong Meng
    Jun Song
    Huan Zhou
    Zongtao Xie
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1353 - 1361
  • [32] Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
    Qiu, Jiliang
    Huang, Pinzhu
    Liu, Qian
    Hong, Jian
    Li, Binkui
    Lu, Canliang
    Wang, Li
    Wang, Jianping
    Yuan, Yunfei
    JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [33] Obesity, colorectal cancer and MACC1 expression: A possible novel molecular association
    Baehr, Ina
    Jaeschke, Lina
    Nimptsch, Katharina
    Janke, Juergen
    Herrmann, Pia
    Kobelt, Dennis
    Kielstein, Heike
    Pischon, Tobias
    Stein, Ulrike
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 60 (02)
  • [34] Correlation of MACC1 and MET Expression in Rectal Cancer after Neoadjuvant Chemoradiotherapy
    Kawamura, Mikio
    Saigusa, Susumu
    Toiyama, Yuji
    Tanaka, Koji
    Okugawa, Yoshinaga
    Hiro, Junichiro
    Uchida, Keiichi
    Mohri, Yasuhiko
    Inoue, Yasuhiro
    Kusunoki, Masato
    ANTICANCER RESEARCH, 2012, 32 (04) : 1527 - 1531
  • [35] Expression of ALDH1, MACC1, and KAI1 in the triple-negative breast cancer and their clinical significance
    Han, Zhengquan
    Gong, Xiaomeng
    Zhu, Bo
    Wu, Shiwu
    Yu, Lan
    Song, Wenqing
    Wang, Danna
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (05): : 5655 - 5664
  • [36] MACC1 expression as a candidate prognostic biomarker in colorectal cancer patients receiving adjuvant oxaliplatin-based therapy
    Symonds, Lynn Katherine
    Baker, Kelsey K.
    Redman, Mary Weber
    Koch, Lisa
    Carter, Kelly
    Yu, Ming
    Wirtz, Ralph
    Poulios, Christos
    Pentheroudakis, George E.
    Papaxoinis, George
    Pectasides, Dimitrios G.
    Kalogeras, Konstantine T.
    Fountzilas, George
    Grady, William M.
    Cohen, Stacey
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [37] Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis
    Sun, Da-Wei
    Zhang, Ying-Yi
    Qi, Yue
    Liu, Gui-Qi
    Chen, Yu-Guo
    Ma, Jian
    Lv, Guo-Yue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 4769 - 4777
  • [38] Relationship between the expression of various markers and prognostic factors in breast cancer
    Anim, JT
    John, B
    Abdulsathar, SA
    Prasad, A
    Saji, T
    Akhtar, N
    Ali, V
    Al-Saleh, M
    ACTA HISTOCHEMICA, 2005, 107 (02) : 87 - 93
  • [39] Correlation of MACC1/c-Myc Expression in Endometrial Carcinoma with Clinical/Pathological Features or Prognosis
    Zhang, Qinghua
    Xu, Ping
    Lu, Yanxia
    Dou, Hongtao
    MEDICAL SCIENCE MONITOR, 2018, 24 : 4738 - 4744
  • [40] The expression of MACC1 and its role in the proliferation and apoptosis of salivary adenoid cystic carcinoma
    Li, Haifeng
    Liao, Xiaoying
    Liu, Yeqing
    Shen, Zhuojian
    Gan, Xiangfeng
    Li, Haigang
    Huang, Zhiquan
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2015, 44 (10) : 810 - 817